Albumin, Aggregated
drug drugOn this page
Also known as Albumin aggregatedAlbuminaggregatedMP 4006MP-4006Perflutrenhuman albumin microspheres
Summary
Albumin, Aggregated (CHEMBL2108890) is an approved protein (ATC V08DA01); indicated across 1 condition.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Protein
- ATC class: V08DA01
- Indications: 1 condition
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108890 |
| Name | Albumin, Aggregated |
| Type | Protein |
| Max phase | 4 |
| ATC | V08DA01 |
Also known as: Albumin aggregated, Albumin, aggregated, MP 4006, MP-4006, Perflutren, human albumin microspheres, ALBUMIN, AGGREGATED
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
1 indication record carries no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.